OTCMKTS:VTRLY Vitrolife AB (publ) (VTRLY) Stock Price, News & Analysis $14.98 0.00 (0.00%) As of 07/11/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartDividendShort InterestBuy This Stock About Vitrolife AB (publ) Stock (OTCMKTS:VTRLY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Vitrolife AB (publ) alerts:Sign Up Key Stats Today's Range$14.98▼$14.9850-Day Range$14.62▼$17.5052-Week Range$14.62▼$17.66VolumeN/AAverage Volume133 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was founded in 1994 and is based in Gothenburg, Sweden. Read More Receive VTRLY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vitrolife AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Email Address VTRLY Stock News HeadlinesReport from Annual General Meeting of Vitrolife AB (publ) | VTRLY Stock NewsApril 30, 2025 | gurufocus.comVitrolife AB (publ) Interim report Q1, 2025: Strong performance in EMEAApril 24, 2025 | gurufocus.comPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.July 15 at 2:00 AM | Paradigm Press (Ad)Vitrolife AB (publ) Interim report Q1, 2025: Strong performance in EMEA | VTRLY Stock NewsApril 24, 2025 | gurufocus.comVitrolife AB (publ) Interim report Q1, 2025: Strong performance in EMEA | VTRLY Stock NewsApril 24, 2025 | gurufocus.comVitrolife AB (publ) GAAP EPS of SEK1.02, revenue of SEK 959MJanuary 30, 2025 | seekingalpha.comVitrolife AB (publ) - Interim report Q3, 2023: Profitable growth globally despite headwind in the U.S.October 27, 2023 | finance.yahoo.comVitrolife ABOctober 17, 2023 | wsj.comSee More Headlines VTRLY Stock Analysis - Frequently Asked Questions How have VTRLY shares performed this year? Vitrolife AB (publ)'s stock was trading at $18.7470 at the beginning of 2025. Since then, VTRLY stock has decreased by 20.1% and is now trading at $14.98. How do I buy shares of Vitrolife AB (publ)? Shares of VTRLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today7/15/2025Next Earnings (Estimated)7/17/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:VTRLY CIKN/A Webwww.vitrolife.com Phone46-3-17-21-80-00FaxN/AEmployees1,132Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (OTCMKTS:VTRLY) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vitrolife AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Vitrolife AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VTRLY Stock Alerts